SPI Premium Insight: CLEW Accelerates into TeleICU, Ready to Challenge Status Quo

Two weeks ago, AI analytics platform developer CLEW launched its ICU Conversion and Accelerator programme in the US. The Israeli company says the programme offers customers a ‘first-of-a-kind’ FDA-approved AI algorithm-powered Virtual ICU, an ICU workflow platform, as well as support for healthcare providers to migrate from their legacy Philips eICU systems.  

Referencing Philips in the media announcement reflects more the multinational’s almost total dominance of US teleICU than CLEW’s current aspirations to dethrone it. While Philips will inevitably see its 80% market share challenged as health systems upgrade their teleICU systems, the more intriguing battle will unfold among the vendors below it.